Does INVESTIGATIONAL PRODUCT Cause Hepatic function abnormal? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Hepatic function abnormal have been filed in association with INVESTIGATIONAL PRODUCT. This represents 0.3% of all adverse event reports for INVESTIGATIONAL PRODUCT.
18
Reports of Hepatic function abnormal with INVESTIGATIONAL PRODUCT
0.3%
of all INVESTIGATIONAL PRODUCT reports
2
Deaths
13
Hospitalizations
How Dangerous Is Hepatic function abnormal From INVESTIGATIONAL PRODUCT?
Of the 18 reports, 2 (11.1%) resulted in death, 13 (72.2%) required hospitalization, and 2 (11.1%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INVESTIGATIONAL PRODUCT. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does INVESTIGATIONAL PRODUCT Cause?
Febrile neutropenia (241)
Pneumonia (229)
Acute kidney injury (198)
Pyrexia (189)
Anaemia (176)
Diarrhoea (170)
Sepsis (168)
Dyspnoea (156)
Nausea (134)
Hypotension (130)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which INVESTIGATIONAL PRODUCT Alternatives Have Lower Hepatic function abnormal Risk?
INVESTIGATIONAL PRODUCT vs INVOKANA
INVESTIGATIONAL PRODUCT vs IOBENGUANE I-131
INVESTIGATIONAL PRODUCT vs IOBITRIDOL
INVESTIGATIONAL PRODUCT vs IODINE
INVESTIGATIONAL PRODUCT vs IODINE\IOFLUPANE I-123